Albiglutide: a new GLP-1 receptor agonist for the treatment of type 2 diabetes. | Colorado PROFILES

Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)

Menu

History

Albiglutide: a new GLP

American Heart Associa

See All (2) pages

Contact Us
If you have any questions or feedback please contact us.

Albiglutide: a new GLP-1 receptor agonist for the treatment of type 2 diabetes.

Trujillo JM, Nuffer W. Albiglutide: a new GLP-1 receptor agonist for the treatment of type 2 diabetes. Ann Pharmacother. 2014 Nov; 48(11):1494-501.

View in: PubMed

subject areas

authors with profiles

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)